Browse by ["viewname_eprint_publisher" not defined]

A

Arnold, D. and Hipp, M. and Liersch, T. and Dellas, K. and Koelbl, O. and Hohenberger, W. and Lordick, F. and Suelberg, H. and Sauer, R. and Roedel, C. (2007) Cetuximab, capecitabine, and oxaliplatin (Cet-CapOx) with concurrent radiotherapy (RT) in advanced rectal cancer (RC): Results of a phase I/II trial. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 4042. ISSN 0732-183X, 1527-7755

B

Budach, Volker and Cho, Chie-Hee and Sedlmaier, Benedikt and Wittlinger, Michael and Iro, Heinrich and Engenhart-Cabillic, Rita and Hautmann, Matthias and Strutz, Juergen and Flentje, Michael and Hueltenschmidt, Beatrix and Moser, Lutz and Bleif, Martin and Budach, Wilfried and Staar, Susanne and Becker, Gerd and Tribius, Silke and Feyer, Petra C. and Wernecke, Klaus Dieter and Werner, Jochen (2012) Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer. JOURNAL OF CLINICAL ONCOLOGY, 30 (15supp): 5512. ISSN 0732-183X, 1527-7755

Budach, Volker and Keilholz, Ulrich and Raguse, Jan D. and Knecht, Rainald and Tribius, Silke and Busch, Chia-Jung and Koelbl, Oliver and Hautmann, Matthias and Schreiber, Andreas and Gruen, Arne and Becker, Eva-Tessina and Tinhofer, Inge and Stromberger, Carmen (2015) Comparison of Standard to Split-Dose TPF Induction Chemotherapy followed by Bio-radiation for LASCC of the Head and Neck: Results of the ICRAT randomized Phase II Study. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

D

Dietz, Andreas and Flentje, Michael and Hagen, Rudolf and Bockmuehl, Ulrike and Koelbl, Oliver and Schilling, Volker and Maschmeyer, Georg and Schroeder, Ursula and Sittel, Christian and Goerner, Martin and Lenarz, Thomas and Klussmann, Jens Peter and Guntinas-Lichius, Orlando and Rudack, Claudia and Reinisch, Sabine and Foerg, Thomas and Westhofen, Martin and Welkoborsky, Hans Juergen and Esser, Dirk and Keilholz, Ulrich (2014) Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

H

Hecht, Markus and Gostian, Antoniu-Oreste and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Hautmann, Matthias G. and Brunner, Thomas and Laban, Simon and Klautke, Gunther and Tamaskovics, Balint and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Roedel, Claus and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Fietkau, Rainer (2020) A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial). In: 2020 ASCO Annual Meeting I - Virtual Scientific Program.

Hofheinz, R. and Wenz, F. K. and Post, S. and Matzdorff, A. and Laechelt, S. and Hartmann, J. T. and Mueller, L. and Link, H. and Moehler, M. H. and Kettner, E. and Fritz, E. and Hieber, U. and Lindemann, H. W. and Grunewald, M. and Kremers, S. and Constantin, C. and Hipp, M. and Gencer, D. and Burkholder, I. and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 3504. ISSN 0732-183X, 1527-7755

K

Kuhnt, Thomas and Schreiber, Andreas and Pirnasch, Anett and Hautmann, Matthias and Hass, Peter and Sieker, Frank and Engenhart-Cabilic, Rita and Richter, Michael and Dellas, Kathrin and Dunst, Juergen (2013) Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.

L

Liersch, T. and Weiss, C. and Dellas, K. and Hipp, M. and Sauer, R. and Roedel, C. and Arnold, D. (2011) Effect of pathohistologic complete remission (pCR) rate on the prediction of long-term prognosis following chemoradiotherapy (XRT) with cetuximab (Cet), capecitabine (CAP), and oxaliplatin (OX; Cet-CAPOX) in patients (pts) with locally advanced rectal cancer (LARC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): e14035. ISSN 0732-183X, 1527-7755

S

Schaefer, Christof and Dietl, Barbara and Loew, Thomas H. and Koelbl, Oliver (2006) What about the family when a terminally ill cancer patient makes a request for euthanasia? JOURNAL OF CLINICAL ONCOLOGY, 24 (19). pp. 3211-3212. ISSN 0732-183X

W

Wilkowski, R. and Rau, H. and Bruns, C. and Wagner, A. and Sauer, R. and Hohenberger, W. and Koelbl, O. and Heinemann, V. (2006) Randomized phase II trial comparing gemcitabine/cisplatin-based chemoradiotherapy (CRT) to 5-FU-based CRT in patients with locally advanced pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 24 (18Supp): 4038. 188S. ISSN 0732-183X